Plano Aesthetics Offers New Breast Cancer Risk Assessment Test
The HALO Breast Pap test will change young women's lives.
Plano, TX – April, 2009 – Dr. Caruth, M.D., now offers a revolutionary new test for breast cancer risk called the HALO Breast Pap test: a 5-minute, non invasive way to assess a woman’s risk for developing Breast Cancer. HALO looks for abnormal cellular changes within the milk ducts where most breast cancer originates.
The HALO Breast Pap Test identifies women who are at high risk for developing breast cancer -- and therefore can benefit from lifestyle changes, increased monitoring, or medical interventions. These steps are aimed at preventing the disease and helping to detect it at its earliest, most treatable stage.
HALO helps to solve a major dilemma in breast healthcare. Traditional methods for assessing breast cancer risk such as review of family history are not particularly effective. Eighty-nine percent of breast cancer patients do not have a family history of the disease. Moreover, of the nearly 180,000 women who will be diagnosed with breast cancer this year, 70 percent will have no identifiable risk factor other than age.
"This is a true medical breakthrough for young women," said Dr. Caruth. "Besides self exams, there has never been a screening test for young women. The HALO Breast Pap Test will detect pre-cancer cells, just like an annual pap test."
The HALO Breast Pap Test uses a new method for collecting nipple aspirate fluid (NAF). NAF is secreted from the milk ducts where 95 percent of invasive breast cancers begin. NAF is collected by the HALO system using warmth, massage and suction, much like a breast pump. The process, which takes only five minutes, is inexpensive, noninvasive and easily accomplished in an annual well-woman visit.
The presence of abnormal cells, or atypia, in NAF is proven to increase a woman's chance of developing breast cancer by four- to five-fold. Available for Interview: Dr. Jeffrey Caruth
- Why is screening for breast cancer risk so important?
- Does HALO replace mammograms?
- What about family history?
- Who should have HALO and how often?
- Demonstration/interview with a female patient, 40 or younger, receiving the HALO Breast Pap Test.
HALO is made by NeoMatrix, an Irvine, Calif., company that develops innovative devices that allow women and their doctors to promote optimal breast health.
About Dr. Caruth Dr. Jeffrey Caruth is the on-site Medical Director at Plano Aesthetics, where he specializes in body contouring and is certified in The Body Jet, SmartLipo and VASER Liposelection. He is also an OBGYN with his own practice where he provides exceptional reproductive care for women from conception to menopause. Dr. Caruth provides NovaSure for women suffering from heavy bleeding, Essure for quick, permanent birth control and the HALO Breast Pap test, a 5-minute, non invasive way to assess a woman’s risk for developing Breast Cancer.
Dr. Caruth is one of only a few physicians in the Southwest to provide SmartLipo MPX, the newest generation of body sculpting. Dr. Caruth is the only physician in North Texas licensed to provide the Dr. TED Diet. In addition to an easy to follow diet plan and nutritional counseling, patients are given a patented endorphin releasing cream to suppress appetite and improve metabolism as well as B12 and B6 shots that contain three fat burning amino acids. Dr. Caruth is devoted to providing the latest technology in body contouring and trains physicians all over the world to use Smartlipo, Vaser and Body-Jet. Plano Aesthetics has established itself as a leading force in bringing innovative cosmetic procedures to the DFW area. Dr. Caruth has been a Diplomat of The American Board of Obstetrics and Gynecology for more than fifteen years. He is an Associate of the Academy of Cosmetic Surgery, a member of the Academy of Cosmetic Gynecology as well as the American Society for Laser Medicine and Surgery. Dr. Caruth’s offices are located at 3108 Midway Road, Suite 102A and 102B. 972-985-8080.
About NeoMatrix NeoMatrix© develops innovative devices that allow women and their doctors to promote optimal breast health. The HALO Breast Pap Test is the first fully automated, noninvasive breast disease-screening device designed for use in the primary care setting. For further information, visit www.neomatrix.com.
